Drugs Made In America Acquisition Corp

NASDAQ • Financial Services • Shell Companies • Quote as of 10/27/2026 12:54

Company Profile

IndustryShell Companies

SectorFinancial Services

ExchangeNASDAQ

Market Capitalization264.13 mln

Float23.43 mln

Earnings Date11/18/2026

EPS

0.20

Overpriced

P / E

55.05

Richly valued

Piotroski F-Score

3 / 9

Below average

Relative Strength

83 / 100

Strongly outperforming

Debt / Equity

0.01

Debt-free

ROE

2.86

Very low

Business Description

Founded in 2024 and headquartered in Fort Lauderdale, Florida, Drugs Made In America Acquisition Corp. is a shell company set up to find and complete a deal with an existing business. The company is open to various deal structures, including mergers, asset purchases, or other transactions that would bring an operating business under its umbrella.

Key Fundamentals

EPS0.20

P/E55.05

ROE2.86

ROIC-1.19

ROA2.76

EBITDA, mln-2.63

EV / EBITDA54.91

EV / EBIT54.91

Quote Details

Last 11.00

Change -0.01 (-0.09%)

Open 11.00

Volume 209

Turnover 2,299

Average Volume 2,508.81

Financial Ratios

Leverage Ratio1.07

Current Ratio0.02

Price / Book1.92

Debt / Equity0.01

Financial Strength

Piotroski F-Score 3 / 9

Price Performance & Relative Strength

Period	Price Performance	Relative Strength
1 Week	0.09%	51 / 100
1 Month	5.47%	87 / 100
2 Months	3.97%	79 / 100
6 Months	8.59%	78 / 100